MedTrace Logo

Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy

NCT04330755 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-10-16

No results posted yet for this study

Summary

In pediatric patients ,undergoing elective surgical correction of aortic coarcatation one of our main concern is spinal cord protection .Our aim to study the protective effect of levosimendan versus its combination with magnesium sulphate .

Conditions

  • Aortic Coarctation

Interventions

DRUG

Saline Solution

Placebo

DRUG

Levosimendan

Levosimendan

DRUG

Magnesium Sulfate

Magnesium Sulfate

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Dalia Saad Abd-El Kader

    lead OTHER

Principal Investigators

  • Amel HY Abelala, professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-04
Primary Completion
2023-03-30
Completion
2023-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04330755 on ClinicalTrials.gov